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Abstract Smooth muscle cell calponin (hi or basic isoform) is 
an actin-binding protein that inhibits actomyosin MgATPase 
activity and is abundantly expressed in differentiated smooth 
muscle. Western blots showed bovine tracheal (BT) smooth 
muscle cells in culture expressed only 2 ± 1 % (n = 8) of the 
amount of calponin in tissues, while NIH-3T3 fibroblasts 
expressed none. We tested the hypothesis that introduction of 
calponin to cultured BT and 3T3 cells would inhibit cytoskeletal 
activities associated with cell proliferation. To achieve high-
efficiency expression, an adenovirus encoding the CMV-calponin 
construct (Adv-CaP) was generated by homologous recombina-
tion in 293 cells. With greater than 90% of BT and 3T3 cells 
infected with Adv-CaP, calponin expression (32 and 11 (tg/mg 
total protein, respectively) was similar to that in smooth muscle 
tissues (51 ng/mg). Cells were infected with Adv-CaP for 48 h, 
replated at low density and proliferation rates were assessed by 
cell density and |3H]thymidine incorporation. Cell growth and 
DNA synthesis by Adv-CaP-infected cells were inhibited to one-
third control values for both BT and 3T3 cells. Expressed 
calponin was localized primarily on stress fibers in both cell 
types. Calponin may act at the cytoskeletal level to retard 
signaling pathways that normally lead to tight coupling between 
cell shape and DNA synthesis. 
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1. Introduction 
Smooth muscle cell (SMC) calponin (also hi or basic cal-
ponin) is a thin filament-associated protein expressed exclu-
sively in smooth muscle cells in adult animals [1,2]. SMC 
calponin is implicated in actin-linked regulation because it 
inhibits smooth muscle actin-activated myosin MgATPase 
and this inhibition can be reversed by phosphorylation or 
binding of Ca2 + /calmodulin in vitro [3-5]. In smooth muscle 
cells, calponin can also promote actin filament stability in 
vitro by inhibiting depolymerization [6]. SMC calponin is lo-
calized to actin-containing filaments [7-9]. Its enrichment in 
the cytoskeletal (myosin-deficient) domains, including dense 
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bodies and dense plaques, of chicken gizzard cells suggests 
that SMC calponin may perform as yet undefined cytoskeletal 
functions [10,11]. 
In order to assess the effects of S M C calponin on actin- and 
myosin-dependent functions in intact smooth muscle cells, we 
have taken advantage of the fact that S M C calponin is rapidly 
down-regulated in SMCs placed in culture [7,8]. Introduction 
of the S M C calponin gene to these cells and to non-muscle 
cells should yield insights into potential contractile and cyto-
skeletal functions of the re-expressed calponin. Results may 
also bear on potential functions of other isoforms of calponin 
(neutral (h2) and acidic) which have a wider tissue distribution 
and are likely to affect processes other than contraction 
[12,13]. Interpretation of the effects of exogenous protein on 
functions in a populat ion of cells depends critically on achiev-
ing high-efficiency expression. We have accomplished this by 
constructing a recombinant, replication-defective adenovirus 
containing the avian SMC calponin cDNA. The present re-
port documents the utility of this approach for introduction 
of contractile proteins into smooth muscle cells. In addition, 
we demonstrate that SMC calponin expression in cultured 
cells inhibits proliferation, establishing a potential cytoskeletal 
action for this abundant smooth muscle protein. 
2. Materials and methods 
2.1. Cell culture 
Bovine tracheal (BT) smooth muscle cells were isolated and pre-
pared for primary culture as previously described [14]. BT cells and 
NIH-3T3 cells were maintained at 37°C, 5°/, C0 2 in DMEM medium 
containing 10% fetal bovine serum, 1% antibiotic-antimycotic (GIB-
CO BRL). BT cells were used at passage 2-3. 
2.2. Construction of recombinant adenovirus and cell infection 
Adv-CaP, the replication-defective, recombinant adenovirus encod-
ing avian SMC calponin was constructed and prepared according to 
standard methods [15,16]. The cDNA encoding chicken SMC calpo-
nin was placed under transcriptional control of the constitutive cyto-
megalovirus (CMV) promoter/enhancer present in the pACSk2CMV5 
shuttle vector [17]. The pAC^CMVS vector was derived from the 
previously described pAC vector. It contains 8.1 map units of adeno-
viral genomic sequence (0-1.4 and 9.1-15.8), the pBluescript SK-vec-
tor, and the expression cassette from pCMV5 including the CMV 
promoter, polylinker, and SV40 polyadenylation sequence. A 923 
base pair BgHI/Clal fragment of the SMC calponin cDNA that con-
tains the entire protein-coding region was subcloned into the 
pACSk2CMV5 vector. The resulting plasmid, pAC-CaP, was co-trans-
fected with pJM17 into 293 cells (adenovirus ElA-transformed human 
embryonic kidney cells) by calcium phosphate/DNA co-precipitation. 
pJM17 is a bacterial plasmid in which a circularized, full-length ad-
enovirus 5 genome is interrupted at 3.7 map units by insertion of the 
plasmid pBRX. Adv-CaP was generated as a result of homologous 
recombination between the two plasmids yielding a genome in which 
the adenovirus early region 1 is replaced by the chimeric gene, causing 
the recombinant virus to be replication defective. Vectors 
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pACsi(.2CMV5 and pJM17 and adenovirus encoding fi-galactosidase 
(Adv-Pgal) were generously provided by Dr. J. Alcorn (UT South-
western Medical Center). High-titer viral stocks (>109 plaque forming 
units (PFU)/ml) for Adv-CaP and Adv-Pgal were obtained following 
selection of individual viral plaques, propagation in 293 cells, and 
purification by CsCl density centrifugation, as described [16]. Titers 
of viral stocks were determined by plaque assay in 293 cells. Aliquots 
of concentrated viral stocks were stored at — 80°C and thawed for use 
before each experiment. 
BT and 3T3 cells cultured in 60 mm plates to 90% confluence were 
infected with different concentrations of purified recombinant adeno-
virus at 0.5 ml/60 mm plate for 1 h. Fresh medium was added and 
incubation continued for 48-72 h before harvesting cells subsequent 
to incubation in trypsin/EDTA. Efficiency of gene transfer was as-
sessed by staining Adv-Pgal-infected cells with isopropylthio-P-D-ga-
lactoside to detect P-galactosidase activity [18]. 
2.3. Growth assay 
Adv-CaP- and Adv-pgal-infected NIH-3T3 and BT smooth muscle 
cells as well as uninfected cells were plated in duplicate at 4 x 104 cells 
per well in 24-well plates. Cells were fixed with methyl alcohol and 
stained with Eosin Y and Thiazine dyes using Diff-Quik Staining Set 
(Baxter). Cell numbers were counted with results derived from the 
average of three random fields (1 mm2) per well, with two wells per 
condition. 
2.4. Immunocytochemistry 
Cells were plated on cover slips and infected by Adv-CaP or trans-
fected with pAC-CaP using lipofectamine (GIBCO BRL) according to 
the recommendations of the manufacturer. After 48 h, cells were fixed 
and immunofluorescence-stained for calponin and F-actin with mono-
clonal anti-chicken smooth muscle calponin antibody (Sigma), fol-
lowed by fluorescein-labeled goat anti-mouse IgG (Sigma) and rhod-
amine-phalloidin. Fluorescence images were acquired using a cooled 
CCD camera as previously described [19]. 
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Fig. 2. Proliferation of smooth muscle cells and fibroblasts infected 
by Adv-CaP. Top panel: Growth curves of uninfected BTC (con-
trol) or those infected by Adv-CaP or Adv-Pgal at 3X109 PFU/ml 
( > 9 5 % efficiency). Bottom panel: Growth curves of uninfected 
NIH-3T3 cells or those infected by Adv-CaP or Adv-Pgal at 
9X 1010 PFU/ml ( > 8 0 % efficiency). 
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Fig. 1. Calponin expression in smooth muscle cells and fibroblasts. 
Endogenous CaP content was measured in bovine tracheal tissue 
homogenates (BT tis), tracheal cells in primary culture (BT Pr), tra-
cheal cells following one or two passages (BT PI, BT P2, respec-
tively) and in cultured NIH-3T3 fibroblasts (3T3). Content of exoge-
nous calponin expressed 72 h after infection with Adv-CaP was 
measured in pass 3 BT cells (BT-AvC) and NIH-3T3 cells (3T3-
AvC). Tracheal cells were infected at 3x10° PFU/ml and 3T3 cells 
at 9 x 1010 PFU/ml. « = 3-6 dishes collected in three separate experi-
ments. 
2.5. Purification of smooth muscle calponin 
Tracheal smooth muscle calponin was partially purified from fresh 
bovine trachealis by a modification of the method described for bo-
vine aorta [4]. All steps were identical with the omission of ion ex-
change and gel filtration chromatography. This resulted in a protein 
preparation containing 50% calponin as assessed from densitometry of 
Coomassie Blue-stained gels. Expressed avian calponin was purified 
from bacterial lysates as described [17]. 
2.6. [sH]Thymidine incorporation assay 
Infected and control cells were plated at 4 x 104 cells per well in 24-
well plates. After 48 h, [3H]thymidine was added to the medium fol-
lowed by a 2-h incubation. Cells were then washed twice with phos-
phate-buffered saline (PBS; GIBCO BRL), and treated with 5% tri-
chloroacetic acid for 30 min. Cells were harvested by trypsin/EDTA 
and lysed by adding 0.1 M NaOH for 30 min. [3H]Thymidine incor-
poration into DNA was measured by liquid scintillation spectroscopy. 
2.7. Western blot analysis 
Cells were collected in SDS sample buffer and solubilized proteins 
subjected to electrophoresis in 10% or 3-20% polyacrylamide gels as 
described previously [14]. Protein concentrations were determined 
with the BCA assay (Pierce). For detection of calponin, proteins sep-
arated by 10% PAGE were transferred to nitrocellulose and blotted 
with monoclonal anti-human calponin antibody (Sigma) for BT tis-
sues and cells as well as NIH-3T3 fibroblasts, or with monoclonal 
anti-chicken smooth muscle calponin antibody (Sigma) for detection 
of avian calponin in Adv-CaP-infected BT and NIH-3T3 cells. For 
detection of a-actin, myosin heavy chains and caldesmon, proteins 
separated by 3-20% PAGE were transferred to nitrocellulose and 
blotted with monoclonal anti-smooth muscle a-actin (Sigma) or poly-
clonal antibodies raised in this laboratory against bovine tracheal 
smooth muscle myosin or chicken gizzard caldesmon. Immunoreactive 
bands were visualized by chemiluminescence (ECL, Amersham) fol-
lowing treatment with secondary antibodies conjugated to horseradish 
peroxidase. Immunoblots were subjected to scanning laser densitom-
etry for quantification. 
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Fig. 3. Concentration dependence of smooth muscle and fibroblast cell growth on Adv-CaP. Cell growth was assessed by measurements of cell 
density and [3H]thymidine incorporation. Cells were infected by indicated amounts of Adv-CaP or Adv-Pgal. After 72 h cells, including unin-
fected (control) cells, were replated at equivalent number per plate. Cell densities were measured after 4 days. [3H]thymidine incorporation was 
assessed after 48 h. Data points in top panels represent measurements on duplicate plates; data in lower panels are mean±SE for three plates. 
3. Results 
The infective efficiency of recombinant adenovirus was as-
sessed in BT smooth muscle cells and NIH-3T3 fibroblasts 
following treatment by different multiplicities of infection 
(MOI) with Adv-|3gal. Cells showed maximal staining for |3-
galactosidase activity at 48-72 h after infection. BT smooth 
muscle cells were more sensitive to infection than NIH-3T3 
fibroblasts, with 50% infected cells occurring at MOIs of 10 
and 300 PFU/cell, respectively. High infective efficiency was 
achieved with both BT smooth muscle cells (75 PFU/cell for 
100% efficiency) and NIH-3T3 fibroblasts (1000 PFU/cell for 
80-90% efficiency). 
Contents of endogenous calponin in bovine tracheal tissue, 
cultured cells and NIH-3T3 fibroblasts were compared to 
amounts of avian calponin expressed in smooth muscle cells 
and fibroblasts infected with Adv-CaP (Fig. 1). Calponin con-
tent was assessed by Western blotting with monoclonal anti-
bodies specific for mammalian calponin or avian calponin. 
Amounts were calculated according to standard curves ob-
tained with purified bovine tracheal calponin or bacterially 
expressed chicken gizzard calponin as appropriate. Consistent 
with results of others [7,8], calponin expression was dimin-
ished in cultured smooth muscle cells as compared to tissue 
(Fig. 1). Cultured BT cells expressed a small fraction (0.026, 
n — 9) the amount of calponin in tissue, while NIH-3T3 cells 
expressed none. Serum withdrawal from cultured BT cells did 
not promote re-expression of calponin. Infection of BT cells 
resulted in increases in calponin to amounts similar to those in 
tracheal tissues (64%; Fig. 1). Infected NIH-3T3 cells ex-
pressed about one-third the amount calponin as BT cells 
(Fig. 1). 
Expression of exogenous calponin had no significant effect 
on the contractile protein 'phenotype' of infected SMCs as 
assessed by Western blots for smooth muscle a-actin, myosin 
heavy chains and caldesmon. Antibody reagents for these pro-
teins were smooth muscle-specific (monoclonal anti-a-actin) 
or cross-react with both smooth and non-muscle isoforms 
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Fig. 4. Localization of CaP expressed in smooth muscle cells and fibroblasts. Image of Adv-CaP-infected BT cell shows distribution of CaP by 
fluorescein staining anti-CaP (A) and F-actin by rhodamine-phalloidin staining (C). Image of NIH-3T3 cell transfected with pACsk.2CMV5-CaP 
shows distribution of CaP by fluorescein staining anti-CaP (B) and F-actin by rhodamine-phalloidin staining (D). Bar for all panels = 20 urn. 
(polyclonal anti-myosin heavy chain and caldesmon). The low 
molecular weight isoform of caldesmon was the only form 
detected in either control or infected BT cells (pass 2). The 
ratios of protein contents in calponin-expressing SMCs with 
respect to control cells were 1.07 ± 0.06 for a-actin, 0.93 ± 0.04 
for myosin heavy chains and 0.97 ± 0.14 for caldesmon (n = 4). 
To evaluate cytoskeletal actions of calponin, we compared 
the proliferation of cultured smooth muscle cells and NIH-
3T3 fibroblasts infected by Adv-CaP to Adv-pgal-infected and 
uninfected cells. Cells were infected, then collected after 48-72 
h and replated at equal density in 24-well plates. Cell density 
was assessed daily following fixation and staining over 4 days. 
The rate of increase in cell density for both smooth muscle 
cells and NIH-3T3 cells was significantly diminished by Adv-
CaP compared to control or Adv-pgal conditions (Fig. 2). 
Doubling times (0.693//:) were calculated from exponential 
growth rate constants (k, day -1) obtained in three separate 
experiments. Doubling times were similar for both BT cells 
and 3T3 cells with respective control values of 0.97 ±0.14 and 
0.93 ±0.14 days. These values increased to 3.2 ±1.3 and 
2.5 ± 0.6 days, respectively, for Adv-CaP infected cells. 
Inhibition of cell growth by Adv-CaP was confirmed by 
3[H]thymidine incorporation which mirrored cell density in 
response to viral infection in a concentration-dependent man-
ner (Fig. 3). Specific inhibition of cell growth was observed for 
NIH-3T3 cells at 80% infection, where Adv-CaP reduced cell 
number as well as DNA synthesis to one-fifth control values, 
while Adv-Pgal had no effect. At similar infection efficiency 
BT cells also showed specific depression of cell growth by 
Adv-CaP, which reduced cell number and DNA synthesis to 
40-50% that observed with Adv-Pgal. With the greatest MOI 
of Adv-Pgal, non-specific depression of BT cell growth was 
observed. 
Immunocytochemical staining of BT and 3T3 cells infected 
with Adv-CaP showed calponin localized primarily on fibers, 
although some diffuse cytoplasmic staining was observed (Fig. 
4). Overlaid images of calponin staining and phalloidin bind-
ing showed that calponin was localized on actin-containing 
stress fibers in these cells. In general Adv-CaP-infected cells 
appeared enlarged compared to control cells. 
4. Discussion 
Smooth muscle cells in culture express minute amounts of 
calponin compared to those in tissues [7,8]. In the present 
study we made use of this smooth muscle calponin 'knockout' 
model to investigate the effects of re-expression of SMC cal-
ponin on cell proliferation. In both cultured bovine tracheal 
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smooth muscle cells and NIH-3T3 fibroblasts, which contain 
no endogenous SMC calponin, cell proliferation and DNA 
synthesis were inhibited by calponin. The cell cycle is coupled 
to the cytoskeleton at the Gl/S transition by minimally under-
stood anchorage and shape-dependent signaling pathways 
[20,21]. In addition, progression through mitosis is dependent 
upon the activities of actomyosin in cell rounding, cytokinesis 
and post-mitotic cell spreading [22]. The present results sug-
gest that the actin-binding protein SMC calponin may act to 
retard signaling that normally leads to cell division. 
Efficient transfer of DNA into smooth muscle and fibro-
blast cells was accomplished by use of replication-defective 
adenovirus recombined with cDNA expression cassettes en-
coding calponin or |3-galactosidase. Recombinant adenovirus 
has been previously shown to yield high-efficiency expression 
of |3-galactosidase in both cultured vascular and tracheal my-
ocytes [17,23,24], far exceeding efficiencies achieved with con-
ventional methods of transfection [16]. The observed differ-
ence in sensitivity to infection between BT and 3T3 cells may 
arise from differences in density of viral receptors required for 
attachment or in density of ocv integrins required for internal-
ization [23]. 
SMC calponin in smooth muscle tissues is enriched in the 
cytoskeletal (myosin-deficient) domain that contains non-
muscle (3-actin [10,11]. In addition, calponin has also been 
localized to dense bodies and dense plaques in these cells 
[10]. Our results demonstrate localization of expressed calpo-
nin on actin-containing stress fibers in both BT and 3T3 cells. 
The effects of calponin likely arise from its association with 
actin; calponin expression had no detectable effect on 
amounts or isoforms of contractile proteins studied in these 
cells. Calponin brought about inhibition of proliferation sim-
ilarly in both BT smooth muscle cells and NIH-3T3 fibro-
blasts. In each case cell density and DNA synthesis were pro-
portionally diminished, indicating a generalized slowing of the 
cell cycle. These results suggest that calponin may inhibit the 
normal signaling between cell attachment, shape and spread-
ing and transition to S-phase. While the cytoskeleton is an 
integral component of this signaling pathway, details remain 
to be elucidated [20,21]. The high content of SMC calponin in 
quiescent cells in tissues, its intracellular localization and the 
fact that SMC calponin is rapidly down-regulated in prolifer-
ating smooth muscle cells in vitro and in vivo circumstantially 
support the hypothesis that calponin suppresses proliferation 
in vivo [25]. 
Calponin may also depress proliferation rates by inhibiting 
actomyosin-dependent processes such as cytokinesis or re-
spreading. Consistent with its inhibitory effect on actomyosin 
MgATPase, SMC calponin decreases the rate of actin filament 
translocation over immobilized myosin in in vitro motility 
assays, and reduces shortening velocity or force when intro-
duced into permeabilized smooth muscle fibers or cells [3,5]. A 
less emphasized, but potentially important function of SMC 
calponin may relate to its stabilizing effect on thin filaments 
[6] that might result in resistance to cytoskeletal rearrange-
ments stimulated by exposure to mitogens. 
The adenovirus gene delivery system results in efficient 
transfer of contractile proteins to cultured smooth muscle 
that facilitates studies on populations of cells. We have shown 
that SMC calponin inhibits cell proliferation in both smooth 
and non-muscle cells, an effect that may result from inhibition 
of signaling, actomyosin activity, thin filament turnover or an 
interplay of these. 
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